Citigroup
ELOX

Citigroup’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Citigroup’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-44
Closed -$6K – 6533
2021
Q1 		$6K Sell
44
-83
-65% -$12.7K ﹤0.01% 5869
2020
Q4 		$20K Buy
127
+92
+263% +$11.2K ﹤0.01% 6662
2020
Q3 		$3K Sell
35
-96
-73% -$11.5K ﹤0.01% 7258
2020
Q2 		$15K Sell
131
-95
-42% -$10.8K ﹤0.01% 6839
2020
Q1 		$17K Buy
226
+56
+33% +$9.12K ﹤0.01% 6805
2019
Q4 		$50K Sell
170
-67
-28% -$13.5K ﹤0.01% 6314
2019
Q3 		$43K Buy
237
+42
+22% +$11.9K ﹤0.01% 6222
2019
Q2 		$78K Buy
195
+20
+11% +$8.42K ﹤0.01% 6095
2019
Q1 		$82K Sell
175
-11
-6% -$5.34K ﹤0.01% 5938
2018
Q4 		$89K Buy
186
+32
+21% +$17.7K ﹤0.01% 5752
2018
Q3 		$105K Buy
154
+77
+100% +$49.3K ﹤0.01% 5861
2018
Q2 		$53K Buy
+77
New +$49.9K ﹤0.01% 6244

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citigroup's ELOX Position: Q2 2021 in Review

Citigroup sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2021, closing a stake of 44 shares — an estimated $6K sold.

Citigroup first reported a position in ELOX in Q2 2018 and held it in 12 quarters. The position peaked at $105K in Q3 2018. 46 funds tracked by Wall St. Rank hold ELOX as of Q2 2021.

  • Citigroup reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Citigroup sold 44 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $6K.
  • Citigroup first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
  • Citigroup's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $105K in Q3 2018.
  • 46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.